Mohamed Hussein

Patient‐reported reasons for discontinuing overactive bladder medication

Joshua S. Benner, Michael B. Nichol, Eric S. Rovner et al. · British Journal of Urology · 2009 · 394 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy et al. · Trials · 2018 · 261 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

Jennie H. Best, Byron J. Hoogwerf, William H. Herman et al. · Diabetes Care · 2010 · 252 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · Trials · 2020 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Perception and attitude of healthcare workers in Saudi Arabia with regard to Covid-19 pandemic and potential associated predictors

Mostafa A. Abolfotouh, Adel F. Almutairi, Ala’a BaniMustafa et al. · BMC Infectious Diseases · 2020 · 93 citations · Full text

Health Professions, Health Sciences, Behavioral Health +16